Donate For Public and Patients Store Search

S040 - Systemic Therapies for Dermatologists: A Comprehensive Review and Update

Sunday, February 18; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Utilize newer systemic agents available for psoriasis, atopic dermatitis and alopecia areata.
  • Discuss the risks and benefits of new systemic agents available for cancers such as melanoma and basal cell carcinoma.
  • Optimize management of patients with Stevens Johnson syndrome/toxic epidermal necrosis.

Description

We are in an exciting time with the development of new dermatologic agents, and not just for psoriasis. In this session we will look at some of the newest systemic agents that are now available and being used for alopecia areata, atopic dermatitis, psoriasis, melanoma and basal cell carcinoma. We will also revisit an older agent that may have found a new use in SJS/TEN.

Disclosures

  • Chang, Anne Lynn S., MD: Galderma Laboratories, L.P. – I(Grants/Research Funding); Genentech, Inc. – I(Grants/Research Funding); Merck & Co., Inc – A(H), I(Grants/Research Funding); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Nuskin – I(Grants/Research Funding); Regeneron – A(H);
  • Nunley, Julia R., MD: American Board of Dermatology – B(NC); Springer Science & Business Media – O(H); UpToDate, Inc – O(H); WebMD – O(H);
  • Owen, Cindy, MD: AbbVie – I(Grants/Research Funding); Accuitis, Inc – I(Grants/Research Funding); Aclaris Therapeutics Inc. – I(Grants/Research Funding); Amgen – I(Grants/Research Funding); Bristol-Myers Squibb – I(Grants/Research Funding); Celgene Corporation – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Galderma USA – I(Grants/Research Funding); Janssen Pharmaceuticals, Inc – I(Grants/Research Funding); Novartis – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Sol-Gel Technologies – I(Grants/Research Funding); Valeant Pharmaceuticals North America LLC – I(Grants/Research Funding);
  • Salkey, Kimberly Scott, MD: no financial relationships exist with commercial interests.
  • Simpson, Eric Lawrence, MD: AbbVie – C(Fees), I(Grants/Research Funding); Boehringer Ingelheim – C(Fees); Demira – C(Fees); Dermavant Sciences – C(Fees); Eli Lilly and Company – C(Fees), I(Grants/Research Funding); Forte Biosciences – C(Fees); Galderma Laboratories, LP – I(Grants/Research Funding); Incyte Corporation – C(Fees); Kyowa Hakko Kirin Pharma, Inc. – I(Grants/Research Funding); Leo Pharma Inc. – C(Fees), I(Grants/Research Funding); Menlo Therapeutics Inc. – C(Fees); Merck – I(Grants/Research Funding); Pfizer Inc. – C(Fees), I(Grants/Research Funding); Pierre Fabre Dermo Cosmetique France – C(Fees); Regeneron – C(Fees), I(Grants/Research Funding); Sanofi Genzyme – C(Fees); Valeant Pharmaceuticals International – C(Fees);
  • Tsao, Hensin, MD, PhD: Asana Biosciences, LLC – I(Grants/Research Funding); Epiphany Dermatology – A(H); Massachusetts General Hospital – E(S); Relay Therapeutics – I(Grants/Research Funding); UpToDate, Inc. – O(H); Worldcare Clinical, LLC – C(H);
  • Van Voorhees, Abby S., MD: AbbVie – I(Grants/Research Funding); Celgene – A(H); Celgene Corporation – C(NC), I(Grants/Research Funding); Derm Tech International – C(H); Lilly ICOS LLC – C(NC), I(Grants/Research Funding); Merck & Co., Inc – O(OB); Novartis – C(NC); UCB – C(NC); WebMD – C(H);
Schedule
Sunday, February 18
1:00 PM
Dr. Simpson / Update for atopic dermatitis
1:30 PM
Dr. Van Voorhees / Update for psoriasis
2:00 PM
Dr. Tsao / Update for melanoma
2:30 PM
Dr. Owen / Update for SJS/TEN
3:00 PM
Dr. Salkey / Up date for alopecia areata
3:00 PM
Dr. Chang / Update for basal cell carcinoma
Event Details
  • Date
    Sunday, February 18
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 5A
  • CME Credits
    3.00
  • Type
    New
Directors/Co-Directors
  • Julia R. Nunley, MD, FAAD
Speakers
  • Abby S. Van Voorhees, MD, FAAD
  • Anne Lynn S. Chang, MD, FAAD
  • Cindy Owen, MD, FAAD
  • Eric Lawrence Simpson, MD, FAAD
  • Hensin Tsao, MD, PhD, FAAD
  • Kimberly Scott Salkey, MD, FAAD